Soligenix announces positive results for ricin vaccine; MMR vaccination rates fall just shy of CDC's goal;

> The Centers for Disease Control and Prevention recommends that adults receive the whooping cough vaccine. Story

> India's New Drugs Advisory Committee of Vaccine approved 9 proposals for trials and market authorizations. News

> MMR vaccination rates fell just shy of the CDC's goals for children starting kindergarten. Article

> NIH scientists gained a new understanding of the first steps in flu antibody development. Release

> Soligenix announced positive Phase Ib clinical results with RiVax, its vaccine against ricin exposure. Release

And Finally... Researchers at the University of Cape Town in South Africa have pioneered a new drug that could serve as a single-dose malaria vaccine. More

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.